Published in
Lippincott, Williams & Wilkins, American Journal of Clinical Oncology, 5(30), p. 526-530, 2007
DOI: 10.1097/coc.0b013e318054675c
Links
Tools
COX-2 and NF-KB Overexpression Is Common in Pancreatic Cancer but Does Not Predict for COX-2 Inhibitors Activity in Combination With Gemcitabine and Oxaliplatin:
Journal article published in 2007 by
Stefano Cascinu,
Mario Scartozzi 
,
Giovanna Carbonari,
Chiara Pierantoni,
Lorena Verdecchia,
Cinzia Mariani,
Michela Squadroni,
Stefania Antognoli,
Rosa Rita Silva,
Riccardo Giampieri,
Rossana Berardi
,
Giovanna Carbonari,
Chiara Pierantoni,
Lorena Verdecchia,
Cinzia Mariani,
Michela Squadroni,
Stefania Antognoli,
Rosa Rita Silva,
Riccardo Giampieri,
Rossana Berardi
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 